BIOMEASURE Inc. is seeking to sell its Milford site. Robbin Eynon, Treasurer of Biomeasure, said, "After careful analysis and consideration, Ipsen S.A., parent of BIOMEASURE has made strategic course changes that impact previous proposed plans for the Biomeasure Milford site." He added Ipsen plans to transfer its current manufacturing staff to a new buyer, though they do not yet have a buyer for the property. The parcel for sale, which includes the land and the current 43, 000-square-foot building.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
111.6 EUR | -0.09% |
|
+0.36% | +3.43% |
Jul. 11 | CAC40: maintains gains after reassuring US inflation figures | CF |
Jul. 11 | CAC40: rise without volume, W-Street at its zenith but falls back | CF |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.43% | 10.05B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- IPN Stock
- News Ipsen
- BIOMEASURE To Sell Milford Site